This section is dedicated to recommendations around adverse events resulting from blood component / product transfusion, including recalling samples based on post-donation recipient information and the adverse event reporting pathway.
Copy citation
Petraszko T, Tinmouth A, Tran A, Rajappannair L, Liwski R, Laureano M, et al. Recommendations for the Notification of Recipients of a Blood Component Recall: a NAC and CBS Collaborative Initiative [Internet]. Ottawa: National Advisory Committee on Blood and Blood Products; July 14, 2015 [updated 2023 07 20; cited YYYY MM DD]. Available from: https://nacblood.ca/en/resource/recommendations-notification-recipients-blood-component-recall